Europe

Key therapeutic categories

  • Dermatology
  • Respiratory
  • Oncology
  • Central Nervous System
Western Europe

In the Western Europe region, Glenmark has a strong presence in UK, Germany, and the Netherlands, and are expanding the reach across other key markets such as Spain, Denmark, Sweden and Ireland. Glenmark has a diverse portfolio with a healthy mix of oral solids and semi-solid products focused in niche therapeutic segments. Glenmark’s commercial operations in this region are built through our own front-end sales team, by generating dossier licensing income and providing third party commercial supplies.

  • Glenmark Pharmaceuticals Europe Limited
    Glenmark Pharmaceuticals Europe R&D Limited
    Building Two
    Croxley Green Business Park
    Croxley Green
    WD18 8YA
    Hertfordshire
    United Kingdom
    Tel: +44 (0)1923 202950
    Fax: +44 (0)1923 236692
  • Glenmark Arzneimittel GmbH
    Industriestraße 31
    82194 Gröbenzell
    Germany
    Tel: +49(0)814244392-0
    Fax: +49 (0)814244392-29
  • Glenmark Pharmaceuticals B.V
    Joop Geesinkweg 901
    1114 AB Amsterdam-Duivendrecht
    Tel: +31 (0) 20 561 6127
  • Glenmark Pharmaceuticals Nordic AB
    Medicon Village AB,
    Scheelevägen, Byggnad 301,
    223 63 Lund. Tel: +46 46 275 64 40
    Fax: +46 275 60 11
Contact information:

Markets The geographies we cater to:

  • UK
  • Germany
  • Netherlands
  • Spain

Key therapeutic categories

  • Dermatology
  • Central Nervous System (CNS)
  • Oncology
  • Cardiovascular (CV)
Central Europe

Glenmark entered the Central Eastern Europe market in March 2007 with the acquisition of Medicamenta a.s., a Czech-based pharmaceutical company. This was the first operational subsidiary in Central Europe with presence in both Czech Republic and Slovakia. In July 2008, Glenmark made its entry into Poland by acquiring a portfolio of seven branded products from Actavis. This acquisition complemented Glenmark’s overall strategy for increasing revenue and accelerating growth in the overall region. Glenmark also initiated operations in the Romania market in the same year.

Today, Glenmark has a portfolio of more than 100 products being sold across these markets in Central and Eastern Europe.

Markets The geographies we cater to:

  • Czech Republic
  • Poland
  • Slovakia
  • Romania